Finland joins contest to host European Medicines Agency post Brexit

30 October 2016

Trade group Pharma Industry Finland (PIF) is warmly in favor of Member of Parliament Annika Saarikko’s proposal to move the European Medicines Agency (EMA) to Finland.

A consequence of Brexit, the currently London-based EMA has to be relocated. Other countries, including Ireland and Spain have also declared their official interest in hosting the Agency, which employs about 900 experts responsible for the scientific evaluation, supervision and safety of medicines in the European Union.

“Finland meets the EMA requirements of highly educated workforce and high-level medical expertise. We can provide the Agency with the well-functioning Finnish infrastructure and the stability of a safe country," general manager Jussi Merikallio of Pharma Industry Finland comments on the proposal.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK